M&A Deal Summary

Stryker Acquires Entellus Medical

On December 7, 2017, Stryker acquired medical products company Entellus Medical from EW Healthcare Partners for 662M USD

Acquisition Highlights
  • This is Stryker’s 22nd transaction in the Medical Products sector.
  • This is Stryker’s 9th largest (disclosed) transaction.
  • This is Stryker’s 22nd transaction in the United States.
  • This is Stryker’s 1st transaction in Minnesota.

M&A Deal Summary
Date 2017-12-07
Target Entellus Medical
Sector Medical Products
Buyer(s) Stryker
Sellers(s) EW Healthcare Partners
Deal Type Add-on Acquisition
Deal Value 662M USD

Target

Entellus Medical

Plymouth, Minnesota, United States
Entellus Medical, Inc. is a high-growth global medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of various ear, nose and throat (ENT) disease states. Company has a broad portfolio of ENT products, including the XprESS® Multi-Sinus Dilation System and the LATERA® Absorbable Nasal Implant. Founded in 2006, and headquartered in Plymouth, Minnesota.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Stryker

Kalamazoo, Michigan, United States
Category Company
Founded 1941
Sector Medical Products
Employees52,000
Revenue 20.5B USD (2023)
DESCRIPTION
Stryker's corporate headquarters in Kalamazoo, Michigan.
Stryker's corporate headquarters in Kalamazoo, Michigan.

Stryker is a medical technology company. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties. Stryker was founded in 1941 and is based in Kalamazoo, Michigan.

DEAL STATS #
Overall 32 of 48
Sector (Medical Products) 22 of 35
Type (Add-on Acquisition) 26 of 42
State (Minnesota) 1 of 1
Country (United States) 22 of 33
Year (2017) 4 of 4
Size (of disclosed) 9 of 23
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-10-24 Vexim SA

Balma, France

Vexim SA is a medical device company, designs and markets minimally invasive solutions for the treatment of traumatic spinal pathologies. Company specializes in the development and sale of vertebral compression fracture (VCF) solutions. The company’s flagship product is the SpineJack® system, a mechanical expandable VCF implant for fracture reduction and stabilization. The VEXIM portfolio is highly complementary to the Interventional Spine (IVS) business of Stryker’s Instruments division whose key products include an extensive and innovative portfolio for vertebral augmentation, vertebroplasty and radiofrequency ablation procedures, along with a diagnostic tool and decompression treatment advances for contained disc herniations.

Buy €162M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-06-25 SafeAir AG

Root Längenbold, Switzerland

SafeAir AG is a Swiss medical device company dedicated to the design, development and manufacture of innovative surgical smoke evacuation solutions. The company's smoke evacuation products help reduce staff and patient exposure to hazards associated with surgical smoke.

Buy -

Seller(S) 1

SELLER

EW Healthcare Partners

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1985
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.

DEAL STATS #
Overall 45 of 53
Sector (Medical Products) 21 of 24
Type (Add-on Acquisition) 29 of 34
State (Minnesota) 2 of 2
Country (United States) 40 of 46
Year (2017) 5 of 5
Size (of disclosed) 3 of 22
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-22 Grupo Farmaceutico Biotoscana S.A.

Montevideo, Uruguay

Grupo Farmaceutico Biotoscana S.A. is a biopharmaceutical group that operates in the fast-growing Latin American region and focuses on rapidly growing market segments such as infectious diseases, oncology and onco-hematology, special treatments, immunology and inflammation, and orphan/rare diseases, among others. GBT is currently present throughout 10 Latin American countries where it operates under its companies Biotoscana, United Medical, and LKM. Biotoscana was formed in 1994 and is based in Montevideo, Uruguay.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-02-20 Cognate BioServices

Memphis, Tennessee, United States

Cognate BioServices, Inc. is a fully-integrated contract bioservices organization that provides a systematic level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development and manufacture of cell-based products. Cognate BioServices was founded in 2002 and is based in Memphis, Tennessee.

Buy -
Mergr

Product

Company

Legal